Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cellectar Biosciences

7.65
-0.2500-3.16%
Volume:86.79K
Turnover:680.58K
Market Cap:13.86M
PE:-0.33
High:8.05
Open:8.02
Low:7.57
Close:7.90
Loading ...

Is Cellectar Biosciences (CLRB) Stock Outpacing Its Medical Peers This Year?

Zacks
·
18 Mar

Cellectar Biosciences Enhances CEO and COO Severance Benefits

TIPRANKS
·
18 Mar

Cellectar Biosciences: Promising Future with FDA Clarity and Innovative Radiopharmaceutical Advancements

TIPRANKS
·
15 Mar

Oppenheimer Keeps Their Hold Rating on Cellectar Biosciences (CLRB)

TIPRANKS
·
14 Mar

Cellectar Biosciences Inc (CLRB) Q4 2024 Earnings Call Highlights: Strategic Restructuring and ...

GuruFocus.com
·
14 Mar

Cellectar Biosciences Faces Financial and Legal Turmoil Amidst Restated Earnings

TIPRANKS
·
14 Mar

Cellectar Biosciences Advances Cancer Drug Pipeline

TIPRANKS
·
14 Mar

Q4 2024 Cellectar Biosciences Inc Earnings Call

Thomson Reuters StreetEvents
·
14 Mar

Cellectar Biosciences Earnings Call: Mixed Outlook Amid Successes and Challenges

TIPRANKS
·
14 Mar

Cellectar Biosciences Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
13 Mar

Cellectar Biosciences reports FY24 EPS ($1.40), consensus ($1.57)

TIPRANKS
·
13 Mar

Cellectar Biosciences sees cash runway into 4Q25

TIPRANKS
·
13 Mar

Cellectar Biosciences Says Its Cash Balance Of $23.3M As Of December 31, 2024, Is Adequate To Fund Its Basic Budgeted Operations Into The Fourth Quarter Of 2025

Benzinga
·
13 Mar

Press Release: Cellectar Biosciences Reports Financial Results for Year Ended 2024 and Provides a Corporate Update

Dow Jones
·
13 Mar

Cellectar Biosciences FY 2024 GAAP EPS $(1.40) Beats $(1.59) Estimate

Benzinga
·
13 Mar

Cellectar Biosciences to Present at the 37th Annual Roth Conference

GlobeNewswire
·
11 Mar

Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Thursday, March 13, 2025

GlobeNewswire
·
05 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
03 Mar

BRIEF-Cellectar Biosciences Inc - Receives Nasdaq Notice On Minimum Bid Price Requirement

Reuters
·
01 Feb

BRIEF-Cellectar Biosciences Inc Files For Offering Of Up To 19.2 Million Shares By The Selling Stockholders - SEC Filing

Reuters
·
30 Jan